stavudine has been researched along with HIV Wasting Syndrome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brophy, JC; Chan, AK; Hawkes, MT; Mateyu, G; Mwinjiwa, E; Sodhi, SK | 1 |
Kumwenda, JJ; Manary, M; Moore, E; Ndekha, M; van Oosterhout, JJ; Zijlstra, EE | 1 |
Andersen, O; Gerstoft, J; Katzenstein, TL; Kirk, O; Nielsen, H; Pedersen, C; Vinten, J; Worm, D | 1 |
Becker, SL; Danehower, SC; Fusco, GP; Fusco, JS; Graham, NM; Hansen, NI; Justice, AC; Sherrill, BH; Stein, DS | 1 |
Bruno, F; Gastaut, JA; Lang, JM; Partisani, M; Poizot-Martin, I; Rouviere, O; Saint-Marc, T; Touraine, JL | 1 |
Dankner, WM; Muelenaer, PA; Spector, SA; Viani, RM | 1 |
James, IR; John, M; Mallal, SA; McKinnon, EJ; Moore, CB | 1 |
1 review(s) available for stavudine and HIV Wasting Syndrome
Article | Year |
---|---|
Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube.
Topics: AIDS-Associated Nephropathy; Anti-HIV Agents; Child, Preschool; Drug Therapy, Combination; Female; Gastrostomy; HIV Protease Inhibitors; HIV Wasting Syndrome; HIV-1; Humans; Lamivudine; Nelfinavir; Nephrotic Syndrome; Remission Induction; Stavudine | 1999 |
1 trial(s) available for stavudine and HIV Wasting Syndrome
Article | Year |
---|---|
Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Composition; Cross-Sectional Studies; Drug Therapy, Combination; Glucose Intolerance; HIV Infections; HIV Protease Inhibitors; HIV Wasting Syndrome; Humans; Hyperlipidemias; Indinavir; Lipodystrophy; Male; Middle Aged; Ritonavir; Saquinavir; Stavudine; Surveys and Questionnaires | 2002 |
6 other study(ies) available for stavudine and HIV Wasting Syndrome
Article | Year |
---|---|
Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi.
Topics: Adolescent; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Cyclopropanes; Dideoxynucleotides; Female; HIV Infections; HIV Wasting Syndrome; Humans; Infant; Lamivudine; Malawi; Male; Proportional Hazards Models; Retrospective Studies; Rural Population; Stavudine; Survival Analysis; Tuberculosis, Pulmonary; Zidovudine | 2016 |
The benefit of supplementary feeding for wasted Malawian adults initiating ART.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Retroviral Agents; Body Mass Index; CD4 Lymphocyte Count; Cohort Studies; Dietary Supplements; Drug Therapy, Combination; Female; HIV Infections; HIV Wasting Syndrome; Humans; Lamivudine; Linear Models; Malawi; Male; Middle Aged; Nevirapine; Retrospective Studies; Risk Factors; Soy Foods; Stavudine; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult; Zea mays | 2010 |
Fat wasting--AZT vs. d4T.
Topics: HIV Infections; HIV Wasting Syndrome; Humans; Male; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2002 |
Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Databases, Factual; Disease Progression; Disease-Free Survival; Follow-Up Studies; HIV Infections; HIV Wasting Syndrome; Humans; Proportional Hazards Models; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Cross-Sectional Studies; Energy Intake; Female; Glucose Tolerance Test; HIV Infections; HIV Wasting Syndrome; Humans; Lipids; Lipodystrophy; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Syndrome; Zidovudine | 1999 |
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Cohort Studies; Didanosine; Female; HIV Infections; HIV Protease Inhibitors; HIV Wasting Syndrome; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Time Factors; Zidovudine | 2000 |